Bonafide Relizen

Bonafide is a women's health company that makes Relizen, a non-hormonal supplement for menopause symptom relief derived from a purified pollen extract. It sells direct-to-consumer and through retail channels, positioning itself in the growing category of hormone-free menopause support. According to WellRank's latest index, Relizen ranks 12th in the Menopause and women's health category with 8% AI answer visibility, and the single AI mention captured in the corpus carries a positive tone.

Bonafide is a women's health brand focused on science-backed, non-prescription products for perimenopause and menopause. The company operates primarily as a direct-to-consumer subscription and retail business, selling through its own website and select retail partners. Founding details and headquarters location are not publicly prominent in widely available sources.

• Relizen, a non-hormonal oral supplement for hot flash and menopause symptom relief
• Purified pollen extract (Sérélys) as the active ingredient, sourced from a clinically studied European formulation
• Subscription-based auto-delivery purchasing option
• Positioning around hormone-free and drug-free menopause support
• Retail availability alongside direct online sales

Bonafide Relizen primarily targets women experiencing perimenopause and menopause, particularly those seeking non-hormonal or drug-free alternatives for managing hot flashes and related symptoms. The product is marketed to women in the United States, though the underlying pollen extract has roots in European clinical research. It appeals broadly to the self-directed women's wellness consumer segment.

• A woman in her late 40s or early 50s experiencing frequent hot flashes who prefers to avoid hormone therapy.
• A health-conscious consumer who researches supplement ingredients and wants clinical backing before purchasing.
• A woman who has tried other OTC menopause products and is looking for a differentiated, non-herbal option.
• A subscription-comfortable buyer who values the convenience of auto-replenishment for a daily wellness routine.

Bonafide's funding history and any investment amounts are not publicly disclosed in widely available sources. The company operates as a private direct-to-consumer brand; revenue scale and valuation are not published.

Bonafide has expanded its product line beyond Relizen to include additional women's health supplements addressing sleep, libido, and vaginal health, reflecting a broader platform strategy in the menopause wellness space. The brand has grown its retail presence alongside its direct channel, which is a widely noted direction for DTC health brands in this category. Specific launch dates and details of individual product releases are not confirmed in widely verifiable public sources.

Based on WellRank's current corpus, the single AI mention of Bonafide Relizen is positive, with no neutral or mixed mentions recorded, suggesting AI engines reference it favorably in menopause-related answers. Broader consumer sentiment across review platforms tends to highlight the product's hormone-free credentials and its differentiation from black cohosh or soy-based alternatives. At 8% AI visibility and rank 12 in its category, the brand has an organic foothold but meaningful room to grow its share of AI-generated recommendations.

Exact pricing varies and is subject to change; Bonafide sells Relizen on a one-time or subscription basis, with subscription orders typically offered at a discount. Precise current prices are not published here as they fluctuate, and consumers should check Bonafide's website directly for up-to-date figures.